Oxidative stress and related factors in patients with ankylosing spondylitis

被引:31
|
作者
Solmaz, Dilek [1 ]
Kozaci, Didem [2 ]
Sari, Ismail [1 ]
Taylan, Ali [3 ]
Onen, Fatos [1 ]
Akkoc, Nurullah [1 ]
Akar, Servet [1 ]
机构
[1] Dokuz Eylul Univ, Sch Med, Dept Internal Med, Div Rheumatol, Izmir, Turkey
[2] Adnan Menderes Univ, Sch Med, Dept Biochem, Aydin, Turkey
[3] Tepecik Training & Res Hosp, Clin Rheumatol, Izmir, Turkey
关键词
Oxidative stress; spondylitis; anklylosing; outcome assessment;
D O I
10.5152/eurjrheum.2015.0031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Ankylosing spondylitis (AS) is a chronic inflammatory disease of the spine and sacroiliac joints of unknown etiology. Recent studies have reported increased oxidative stress, which is implicated in the pathogenesis of a number of diseases, in AS. The purpose of this study was to investigate oxidative stress and related factors in AS. Material and Methods: Eighty-five patients with AS [36 (16-64) years; 65 male/20 female] and 56 healthy subjects [36 (21-63) years; 39 male/17 female] with no known cardiovascular risk factors were enrolled. Serum total oxidant status (TOS) and total anti-oxidant status (TAS) were studied. The Bath ankylosing spondylitis functional index (BASFI), Bath ankylosing spondylitis disease activity index (BASDAI), and Bath ankylosing spondylitis metrology index (BASMI) were calculated. A logistic regression model was used to identify the independent risk factors for TOS. Results: No differences were observed in terms of demographic characteristics, laboratory findings, or TAS concentrations between the patient and control groups. However, the serum TOS levels were significantly higher in the AS group than in the controls (p=0.003). The comparison of cases of active (BASDAI >= 4) and inactive AS revealed significantly higher TOS levels in the active disease group. The TOS and TAS concentrations did not differ between patients treated with biological agents and those treated with conventional agents. Correlation analysis yielded significant correlations between TOS and TAS, BASMI, BASFI, BASDAI, erythrocyte sedimentation rate (ESR), and high-sensitive C-reactive protein (hs-CRP) (p<0.05; r values ranged from 0.291 to 0.452) and a positive correlation between TAS and BASMI (p<0.05; r= 0.344). Based on regression analysis, BASDAI, BASMI, and hs-CRP independently predicted the TOS levels [p<0.05, R-2 : 0.262, and standard error of the estimate (SEE): 10.96] Conclusion: Oxidative stress levels were higher in patients with AS than in healthy subjects. Patients with active disease status had significantly higher oxidative stress than patients with inactive disease status and healthy controls. Treatment status has no effect on TOS, and BASMI, BASDAI, and hs-CRP are independent variables associated with TOS. The TAS levels were found to be associated with only BASMI.
引用
收藏
页码:20 / 24
页数:5
相关论文
共 50 条
  • [1] OXIDATIVE STRESS AND ITS RELATED FACTORS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Solmaz, D.
    Kozaci, D.
    Sari, I.
    Guney, N.
    Taylan, A.
    Onen, F.
    Akkoc, N.
    Akar, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 952 - 952
  • [2] Increase in oxidative stress in patients with ankylosing spondylitis
    Stanek, A.
    Cholewka, A.
    Wielkoszynski, T.
    Romuk, E.
    Drzazga, Z.
    Birkner, E.
    Sieron, A.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2013, 43 : 87 - 87
  • [3] Oxidative stress and immunological biomarkers in Ankylosing spondylitis patients
    Danaii, Shahla
    Abolhasani, Rozita
    Soltani-Zangbar, Mohammad Sadegh
    Zamani, Majid
    Mehdizadeh, Amir
    Amanifar, Bahareh
    Yousefi, Bahman
    Nazari, Mehdi
    Pourlak, Tannaz
    Hajialiloo, Mehrzad
    Yousefi, Mehdi
    [J]. GENE REPORTS, 2020, 18
  • [4] Infliximab reduces oxidative stress in ankylosing spondylitis
    Feijoo, M.
    Tunez, I.
    Tasset, I.
    Montilla, P.
    Ruiz, A.
    Collantes, E.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (01) : 167 - 168
  • [5] NATRIURETIC PEPTIDE LEVELS AND THE CORRELATION OF OXIDATIVE STRESS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Calis, M.
    Sonbahar, E.
    Calis, H. Talay
    Yazici, C.
    Demir, F. Ulku
    Mistik, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1039 - 1039
  • [6] Delayed Diagnosis: Related Factors and Outcomes in Patients with Ankylosing Spondylitis
    Fallahi, Sasan
    Jamshidi, Ahmad Reza
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S65 - S65
  • [7] Immunological and oxidative stress biomarkers in Ankylosing Spondylitis patients with or without metabolic syndrome
    Pishgahi, Alireza
    Abolhasan, Rozita
    Danaii, Shahla
    Amanifar, Bahareh
    Soltani-Zangbar, Mohammad Sadegh
    Zamani, Majid
    Kamrani, Amin
    Ghorbani, Farzaneh
    Mehdizadeh, Amir
    Kafil, Hossein Samadi
    Jadidi-Niaragh, Farhad
    Yousefi, Bahman
    Hajialiloo, Mehrzad
    Yousefi, Mehdi
    [J]. CYTOKINE, 2020, 128
  • [8] Infliximab reduces oxidative stress in ankylosing spondylitis Reply
    Kageyama, Y.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (01) : 168 - 168
  • [9] Prevalence of osteoporosis and vertebral fractures and related factors in patients with ankylosing spondylitis
    Mehmet Ali Ulu
    brahim Batmaz
    Banu Dilek
    Remzi evik
    [J]. 中华医学杂志(英文版), 2014, (15) : 2740 - 2747
  • [10] Prevalence of osteoporosis and vertebral fractures and related factors in patients with ankylosing spondylitis
    Ulu, Mehmet Ali
    Batmaz, Ibrahim
    Dilek, Banu
    Cevik, Remzi
    [J]. CHINESE MEDICAL JOURNAL, 2014, 127 (15) : 2740 - 2747